Atlas Trials

A Clinical Trial to Evaluate the Efficacy and Safety of HRS-9821 Inhalation Suspension in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Clinical trial NCT07640451 · RECRUITING

Trial details

NCT number
NCT07640451
Sponsor
Guangdong Hengrui Pharmaceutical Co., Ltd
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
COPD
Start date
2026-07-20
Primary completion
2026-10-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.